President Donald Trump and Pfizer's CEO today announced "TrumpRX" and lower drug prices. But what does Pfizer sell? Here's ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
The wide range of chromatographic techniques share one common aim: to separate a material into its components. A material, your sample, is dissolved in a solvent, called the mobile phase. This mixture ...
Affiliated with the UB Institute for Artificial Intelligence and Data Science, the lab allows Ramanathan and his ...
AI is transforming drug discovery, but accurately predicting patient responses remains challenging. Considering the ongoing need to connect drugs with the right patients and rising drug costs, ...
Could “TrumpRx” be the prescription for lower drug prices? President Trump announced a landmark deal with Pfizer to cut drug prices and sell them on TrumpRx, a new direct-to-consumer federal website ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
The former chair of America’s Council of Economic Advisers wants NATO-style spending targets for innovative medicines ...
Kala Bio will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the drug developer's shares down 93% in ...
Trump administration officials are expected to discuss a medication called leucovorin as a potential treatment for autism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback